Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Invest. 2001 Jan;107(2):163-71.

Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

Author information

1
Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 315 Medical Research Building, Nashville, Tennessee 37232-6300, USA. sergio.fazio@mcmail.vanderbilt.edu

Abstract

During atherogenesis, circulating macrophages migrate into the subendothelial space, internalize cholesterol-rich lipoproteins, and become foam cells by progressively accumulating cholesterol esters. The inhibition of macrophage acyl coenzyme A:cholesterol acyltransferase (ACAT), which catalyzes the formation of cholesterol esters, has been proposed as a strategy to reduce foam cell formation and to treat atherosclerosis. We show here, however, that hypercholesterolemic LDL receptor-deficient (LDLR(-/-)) mice reconstituted with ACAT1-deficient macrophages unexpectedly develop larger atherosclerotic lesions than control LDLR(-/-) mice. The ACAT1-deficient lesions have reduced macrophage immunostaining and more free cholesterol than control lesions. Our findings suggest that selective inhibition of ACAT1 in lesion macrophages in the setting of hyperlipidemia can lead to the accumulation of free cholesterol in the artery wall, and that this promotes, rather than inhibits, lesion development.

PMID:
11160132
PMCID:
PMC198874
DOI:
10.1172/JCI10310
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Society for Clinical Investigation Icon for PubMed Central
    Loading ...
    Support Center